Brief: Femasys Inc Femaseed Localized Directional Insemination For Infertility Receives Product Approval In Canada
18/04/2023 13:03
April 18 (Reuters) - Femasys Inc FEMY.O :
* FEMASYS INC: FEMASEED LOCALIZED DIRECTIONAL INSEMINATION
FOR
INFERTILITY RECEIVES PRODUCT APPROVAL IN CANADA
* FEMASYS INC: POTENTIAL COMMERCIAL LAUNCH OF FEMASEED IN
U.S.
PROJECTED IN 2024, IF CLEARED BY FDA
Source text for Eikon: ID:nGNX3Pp1XH
Further company coverage: FEMY.O
Recent news on Femasys
See all newsBrief: Femasys - Files For Resale Of Up To 28,124,997 Shares Of Common Stock - SEC Filing
Brief: Femasys Announces FDA Approval Of Modular Pma Submission Approach For Fembloc
Femasys Inc reports results for the quarter ended June 30 - Earnings Summary
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview
Femasys Inc expected to post a loss of $1.30 a share - Earnings Preview